What would it actually take to prove, in a board deck rather than a pitch deck, that a marketing partner moved monthly recurring revenue and not just activity volume?
Most growth leaders comparing agencies cannot answer that question cleanly. They can describe the pitch. They can recite the channel mix a shortlisted firm proposed.
What they usually cannot produce is a baseline against which any of it would be judged a success or a failure six months later. That gap, not the quality of any single proposal, is the actual decision being made.
What Monthly Recurring Revenue Outcome Must an Agency Help Create?
A revenue-system outcome and a lead-volume outcome are not the same commitment, even when they are described with the same words in a proposal. Monthly recurring revenue growth is a function of activation rate, conversion at each funnel stage, retention against churn, and the length of the sales cycle a given segment requires.
An agency proposing to “drive growth” without naming which of these levers it intends to move, and by how much, is proposing an activity plan, not a revenue plan.
Before any agency conversation happens, the internal side of the ledger needs to be written down. That means a stated MRR figure, a pipeline conversion rate by stage, an activation benchmark if the product has a free or trial tier, a churn or retention number, and an average sales-cycle length in days.
Each of those numbers needs a named internal owner, someone in finance, revenue operations, or product who can confirm it and defend it later.
This is not paperwork for its own sake. A proposal compared against no baseline cannot be assessed against a baseline six months in.
The written definition of the business problem, agreed internally before any agency sees it, is what turns “did the campaign work” from an opinion into a calculation.
What Does a Poor B2B SaaS Marketing Agency Choice Actually Cost?
The cost of a poor selection rarely shows up as an invoice. It shows up as a quarter, sometimes two, spent producing reports nobody in finance would sign their name to.
The failure modes are recognizable, and each one leaves a specific, checkable trace in a proposal before the contract is signed.
- No attributable baseline. The proposal references growth or performance without a stated starting figure. There is nothing to measure the engagement against later.
- Generic B2B positioning. Case studies and language could apply to any company selling any subscription product. Nothing addresses activation, seat expansion, or usage-based pricing questions specific to SaaS.
- Senior sellers, junior delivery. The person who ran the pitch is not named anywhere in the staffing plan. Delivery is described only by role title, with no continuity commitment.
- Isolated campaigns. Marketing activity is proposed with no stated handoff to sales enablement or customer success, and no mention of how product usage data will inform targeting.
- Unclear attribution. The reporting model cannot separate marketing-influenced pipeline from pipeline that was already in motion.
- Commitments that outlast learning. Contract length exceeds the point at which the agency itself proposes to review results and change course.
Each of these is verifiable in writing before a signature, which is exactly why they belong on a checklist rather than in a gut reaction to a pitch.
Which B2B SaaS Marketing Strategy Fits the Growth Constraint?
Strategic fit is a diagnosis question, not a menu selection.
- Product-led growth
- demand generation
- lead generation
- sales enablement
- lifecycle marketing
- content
- paid acquisition
- brand work
are not competing philosophies so much as different answers to different constraints.
The constraint has to be named before the channel is chosen.
When the Constraint Is Activation, Not Awareness
If the product already has adequate top-of-funnel volume but weak conversion from trial or freemium to paid, the fitting response is product-led growth work aimed at onboarding, in-app messaging, and usage-triggered outreach, not more demand generation spend.
OpenView’s product-led growth benchmarks put the median B2B SaaS freemium-to-paid conversion rate at 2.6%, which is a useful reference point for whether a proposed PLG motion is targeting a realistic lift or an implausible one.
When the Sales Cycle Is Long
Longer sales cycles shift the mix toward sales enablement and lifecycle nurturing, because a single well-timed campaign cannot compress a multi-stakeholder buying process.
This is where the Rule of 7 is worth treating carefully: it describes repeated, coordinated exposure across channels and time, not a volume target to hit with seven emails in a week.
Applied correctly, it argues for sequencing across content, paid, and direct outreach that reinforces the same buying signal, not for more noise.
Brand and content work earn their place only where awareness, not conversion or activation, is the demonstrated constraint.
How Can an Agency’s SaaS Specialization Be Verified Before It Is Hired?
Specialization claims are cheap to make and expensive to take on faith. The verification standard has to be comparability, not resemblance.
A logo wall of recognizable SaaS names proves nothing if none of those companies shared the evaluating company’s business model, average contract value, go-to-market motion, or market maturity.
Proof of Diagnosis
Before execution is discussed, the agency’s diagnostic method should be visible in its own case material.
- Case studies must specify starting conditions: the funnel metrics before engagement, not just the results after.
- Business model comparability must be explicit: usage-based, seat-based, or flat subscription pricing behaves differently, and a case study from a mismatched model tells the evaluator little.
- Average contract value and go-to-market motion (self-serve, sales-assisted, or enterprise) must resemble the evaluator’s own, since a PLG motion built for a $50 monthly plan does not transfer to a six-figure enterprise deal.
- Market maturity should be stated: a category-creation campaign and a campaign in a saturated, competitor-dense market require different assumptions.
- Time-to-learning should be disclosed separately from time-to-revenue, so the evaluator knows how long it took the agency to know whether its own hypothesis was working, distinct from how long it took to show revenue.
What Separates Diagnosis Claims That Hold Up From Ones That Don’t
The table below sets the two proof categories against each other on the same axes, since the distinction between them is easy to state and easy to miss in an actual pitch.
| Axis | Proof of Diagnosis | Proof of Execution |
|---|---|---|
| What it verifies | Whether the agency identified the correct constraint | Whether the agency can act on a constraint once named |
| Where it shows up | Case study starting conditions, business model match | Copy samples, tooling fluency, staffing |
| Failure if absent | A confident plan built on the wrong problem | A correct plan delivered late, badly, or by strangers |
| Who owns the risk | The agency’s strategists | The agency’s delivery team |
A firm that clears the diagnosis column but not the execution column is good at telling a story about outcomes it did not fully control.
A firm that clears execution but not diagnosis is good at execution against someone else’s untested plan.
Proof of Execution
Once diagnosis is credible, execution capability needs its own separate check.
- Pricing-model fluency: can the agency speak accurately about usage-based versus seat-based mechanics and how each affects campaign messaging?
- Conversion copy samples specific to SaaS trial or demo flows, not general brand copy.
- Technical and analytics capability: can the team work inside the evaluator’s existing CRM and analytics stack, or does it require replacing tools that already work?
- AI-use transparency: where AI tools are used in research, copy, or targeting, the agency should say so plainly rather than let it surface later.
- References who will speak candidly, not only the client featured in the polished case study.
When Should Work Stay In-House Rather Than Go to an Agency?
Not every growth problem is an agency problem, and the comparison is not a binary between competent internal marketers and a superior outside firm.
It is a comparison of five specific conditions: institutional product knowledge, specialist capacity, experimentation speed, data access, and where accountability actually sits when a result is questioned.
An internal team usually holds deeper product and customer knowledge and faster access to usage data, but is often constrained by specialist capacity, meaning nobody in-house has run a PLG activation program end to end.
An agency usually brings that specialist capacity and faster experimentation cycles, drawn from having run the same motion elsewhere, but starts with none of the product context and depends entirely on what internal teams choose to share.
The failure mode is not choosing incorrectly between the two. It is treating an agency as a channel operator working in isolation, when product, sales, customer success, and internal marketing each hold inputs an external partner cannot generate independently.
Product holds the roadmap and usage data. Sales holds objection patterns from live deals. Customer success holds churn reasons, and internal marketing holds brand and compliance guardrails.
A shared operating model names who owns which decision and how often those groups meet the agency, not just how often the agency reports upward.
What Pricing, ROI, and Contract Terms Make an Agency Testable?
Cost only means something against scope, and scope only means something against economics that were agreed before the contract was signed.
A serious B2B SaaS PPC retainer typically starts around $4K-$5K monthly minimum and can run to $10K-$15K a month once the agency also owns creative testing, landing pages, and reporting, according to a 2026 SaaS agency pricing guide.
Separately, most serious SaaS marketing retainers as a category fall between $4,000 and $30,000 a month, which is a qualification range to interrogate rather than a benchmark to accept on its own.
The commercial checklist that makes any figure testable includes:
- Scope-to-fee mapping: what specific deliverables the fee covers, versus what triggers an additional charge.
- Paid media and production costs: stated separately from the management fee, not bundled into a single number.
- Measurement access: the evaluator retains admin-level access to analytics and ad accounts, not a summary dashboard only.
- Leading indicators and review cadence: named metrics reviewed on a fixed schedule, distinct from the final revenue number.
- Ownership and exit terms: who keeps the ad accounts, creative assets, and data on termination, and what notice period applies.
A contract that cannot answer these in writing is not ready to be signed regardless of how strong the pitch was.
Which Questions Reveal Whether an Agency Has a Credible Plan?
The value of a discovery call is not the answers an agency gives with confidence. It is whether those answers contain evidence or only assurance.
- First, ask what the agency believes the actual constraint is, before any channel is proposed, and require that the answer reference the baseline data already shared rather than a generic funnel model.
- Second, ask what hypothesis the proposed campaign tests and what signal would prove that hypothesis wrong. A credible answer names a specific disconfirming result; a vague one only names what success would look like.
- Third, ask how each metric is defined and how attribution will separate marketing-influenced revenue from revenue already in the pipeline before the engagement began.
- Fourth, for any product-led growth work, ask what specific in-product experiments are planned and how those experiments interact with the product team’s existing roadmap. A PLG campaign built without engineering coordination cannot ship.
- Fifth, for long sales cycles, ask what sales enablement material the agency will produce and how it will be handed to the sales team, not just delivered to a shared drive.
- Sixth, ask how customer success will be looped in on retention-relevant messaging, since acquisition work that ignores early churn signals creates revenue that unwinds within a quarter.
- Seventh, ask what reporting access will be granted directly, not summarized, and how often it updates.
- Eighth, ask who is actually staffed on delivery, by name, and what their tenure has been on comparable accounts.
- Ninth, call at least one reference who is not featured in the agency’s published case studies.
- Where the campaign involves email or contact outreach, a tenth question belongs in the sequence: how the agency handles consent and opt-out under GDPR where relevant, and how sending practices comply with the CAN-SPAM Act for any list-based outreach. A concrete answer names a specific process; a vague one gestures at “compliance” without naming a mechanism.
A concrete answer to any of these ten cites a document, a number, or a named process. A vague answer restates confidence.
Which Proposal Signals Mean an Agency Should Be Ruled Out?
Certain facts, once observed, end the evaluation regardless of how the rest of the pitch performed. Each is a fact to check against the document in front of you, not an impression to weigh.
- No baseline metric or named internal owner appears anywhere in the proposal.
- Case studies lack comparable starting conditions, business model, or contract value.
- Delivery staffing is unnamed or described only by title.
- Methodology is absent, replaced by outcome claims alone.
- Reporting access is withheld or limited to summary dashboards.
- Contract exit terms conflict with the stated review cadence.
- Compliance responsibility for outreach is undefined.
Any single one of these, confirmed in writing, is sufficient reason to stop the evaluation. The pitch’s strength elsewhere does not offset it.